MEDINET Co., Ltd. (2370.T)
JPY 31.0
(-3.13%)
JPY 31.0
(-3.13%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 5.63 Billion JPY | -7.3% |
| 2022 | 6.07 Billion JPY | 13.02% |
| 2021 | 5.37 Billion JPY | 2.44% |
| 2020 | 5.24 Billion JPY | 70.21% |
| 2019 | 3.08 Billion JPY | -21.66% |
| 2018 | 3.93 Billion JPY | -37.16% |
| 2017 | 6.26 Billion JPY | -18.06% |
| 2016 | 7.64 Billion JPY | -14.06% |
| 2015 | 8.89 Billion JPY | -10.56% |
| 2014 | 9.94 Billion JPY | -18.75% |
| 2013 | 12.24 Billion JPY | 67.38% |
| 2012 | 7.31 Billion JPY | -8.85% |
| 2011 | 8.02 Billion JPY | 39.32% |
| 2010 | 5.75 Billion JPY | 48.08% |
| 2009 | 3.88 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 5.72 Billion JPY | -6.12% |
| 2024 Q1 | 6.34 Billion JPY | 12.68% |
| 2024 Q2 | 6.1 Billion JPY | -3.91% |
| 2023 Q2 | 5.38 Billion JPY | -2.0% |
| 2023 Q3 | 5.54 Billion JPY | 3.06% |
| 2023 Q4 | 5.63 Billion JPY | 1.59% |
| 2023 Q1 | 5.49 Billion JPY | -9.66% |
| 2023 FY | 5.63 Billion JPY | -7.3% |
| 2022 Q1 | 5.5 Billion JPY | 2.36% |
| 2022 FY | 6.07 Billion JPY | 13.02% |
| 2022 Q4 | 6.07 Billion JPY | -2.99% |
| 2022 Q3 | 6.26 Billion JPY | -0.74% |
| 2022 Q2 | 6.31 Billion JPY | 14.66% |
| 2021 Q1 | 5.89 Billion JPY | 12.24% |
| 2021 FY | 5.37 Billion JPY | 2.44% |
| 2021 Q4 | 5.37 Billion JPY | -5.05% |
| 2021 Q3 | 5.66 Billion JPY | -1.48% |
| 2021 Q2 | 5.74 Billion JPY | -2.43% |
| 2020 Q4 | 5.24 Billion JPY | 36.47% |
| 2020 FY | 5.24 Billion JPY | 70.21% |
| 2020 Q2 | 3.42 Billion JPY | 9.19% |
| 2020 Q3 | 3.84 Billion JPY | 12.36% |
| 2020 Q1 | 3.13 Billion JPY | 1.66% |
| 2019 Q1 | 3.58 Billion JPY | -8.97% |
| 2019 Q4 | 3.08 Billion JPY | 2.94% |
| 2019 Q3 | 2.99 Billion JPY | -9.53% |
| 2019 Q2 | 3.31 Billion JPY | -7.59% |
| 2019 FY | 3.08 Billion JPY | -21.66% |
| 2018 Q4 | 3.93 Billion JPY | -11.1% |
| 2018 Q3 | 4.42 Billion JPY | -6.42% |
| 2018 Q2 | 4.73 Billion JPY | -19.88% |
| 2018 Q1 | 5.9 Billion JPY | -5.73% |
| 2018 FY | 3.93 Billion JPY | -37.16% |
| 2017 Q4 | 6.26 Billion JPY | -8.09% |
| 2017 Q2 | 6.9 Billion JPY | -7.43% |
| 2017 Q3 | 6.81 Billion JPY | -1.3% |
| 2017 FY | 6.26 Billion JPY | -18.06% |
| 2017 Q1 | 7.46 Billion JPY | -2.41% |
| 2016 Q1 | 9 Billion JPY | 1.18% |
| 2016 Q2 | 8.68 Billion JPY | -3.54% |
| 2016 Q3 | 8.17 Billion JPY | -5.88% |
| 2016 Q4 | 7.64 Billion JPY | -6.44% |
| 2016 FY | 7.64 Billion JPY | -14.06% |
| 2015 FY | 8.89 Billion JPY | -10.56% |
| 2015 Q2 | 9.48 Billion JPY | -1.61% |
| 2015 Q1 | 9.63 Billion JPY | -3.14% |
| 2015 Q4 | 8.89 Billion JPY | -5.93% |
| 2015 Q3 | 9.45 Billion JPY | -0.23% |
| 2014 Q3 | 10.81 Billion JPY | -3.57% |
| 2014 Q2 | 11.21 Billion JPY | -6.19% |
| 2014 Q1 | 11.95 Billion JPY | -2.31% |
| 2014 FY | 9.94 Billion JPY | -18.75% |
| 2014 Q4 | 9.94 Billion JPY | -8.05% |
| 2013 Q2 | 7.58 Billion JPY | 2.78% |
| 2013 Q3 | 13.07 Billion JPY | 72.26% |
| 2013 Q4 | 12.24 Billion JPY | -6.36% |
| 2013 FY | 12.24 Billion JPY | 67.38% |
| 2013 Q1 | 7.38 Billion JPY | 0.96% |
| 2012 Q3 | 7.45 Billion JPY | -2.67% |
| 2012 Q4 | 7.31 Billion JPY | -1.87% |
| 2012 FY | 7.31 Billion JPY | -8.85% |
| 2012 Q1 | 7.66 Billion JPY | -4.45% |
| 2012 Q2 | 7.65 Billion JPY | -0.12% |
| 2011 FY | 8.02 Billion JPY | 39.32% |
| 2011 Q1 | 8.18 Billion JPY | 42.19% |
| 2011 Q2 | 8.37 Billion JPY | 2.32% |
| 2011 Q3 | 7.98 Billion JPY | -4.73% |
| 2011 Q4 | 8.02 Billion JPY | 0.51% |
| 2010 Q1 | 4 Billion JPY | 3.09% |
| 2010 Q2 | 4.1 Billion JPY | 2.47% |
| 2010 FY | 5.75 Billion JPY | 48.08% |
| 2010 Q4 | 5.75 Billion JPY | 1.76% |
| 2010 Q3 | 5.66 Billion JPY | 37.76% |
| 2009 FY | 3.88 Billion JPY | 0.0% |
| 2009 Q2 | 2.83 Billion JPY | 0.86% |
| 2009 Q4 | 3.88 Billion JPY | 0.0% |
| 2009 Q1 | 2.81 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 6.58 Billion JPY | 14.496% |
| PRISM BioLab Co.,LTD | 1.21 Billion JPY | -365.084% |
| GNI Group Ltd. | 62.39 Billion JPY | 90.97% |
| Linical Co., Ltd. | 18.53 Billion JPY | 69.611% |
| Trans Genic Inc. | 9.81 Billion JPY | 42.573% |
| Soiken Holdings Inc. | 6.94 Billion JPY | 18.888% |
| Cytori Cell Research Institute, Inc. | 5.81 Billion JPY | 3.132% |
| AnGes, Inc. | 28.89 Billion JPY | 80.5% |
| OncoTherapy Science, Inc. | 867.27 Million JPY | -549.638% |
| Nxera Pharma Co., Ltd. | 157.19 Billion JPY | 96.416% |
| Immuno-Biological Laboratories Co., Ltd. | 1.61 Billion JPY | -248.091% |
| NanoCarrier Co., Ltd. | 5.07 Billion JPY | -11.099% |
| Carna Biosciences, Inc. | 4.34 Billion JPY | -29.524% |
| CanBas Co., Ltd. | 2.43 Billion JPY | -131.586% |
| D. Western Therapeutics Institute, Inc. | 2.37 Billion JPY | -137.39% |
| RaQualia Pharma Inc. | 6.93 Billion JPY | 18.702% |
| Chiome Bioscience Inc. | 1.75 Billion JPY | -221.684% |
| Kidswell Bio Corporation | 5.08 Billion JPY | -10.787% |
| PeptiDream Inc. | 67.12 Billion JPY | 91.607% |
| Oncolys BioPharma Inc. | 2.04 Billion JPY | -176.103% |
| Ribomic Inc. | 3.54 Billion JPY | -58.831% |
| SanBio Company Limited | 5.04 Billion JPY | -11.627% |
| Healios K.K. | 15.15 Billion JPY | 62.823% |
| BrightPath Biotherapeutics Co., Ltd. | 1.23 Billion JPY | -357.965% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 3.01 Billion JPY | -86.809% |
| Delta-Fly Pharma, Inc. | 1.47 Billion JPY | -282.195% |
| StemRIM | 9.08 Billion JPY | 37.95% |
| CellSource Co., Ltd. | 6.87 Billion JPY | 18.105% |
| FunPep Company Limited | 2.49 Billion JPY | -126.168% |
| Kringle Pharma, Inc. | 2.61 Billion JPY | -115.154% |
| Stella Pharma Corporation | 3.82 Billion JPY | -47.467% |
| TMS Co., Ltd. | 3.55 Billion JPY | -58.496% |
| Noile-Immune Biotech Inc. | 5.77 Billion JPY | 2.506% |
| Cuorips Inc. | 6.18 Billion JPY | 8.902% |
| K Pharma,Inc. | 3.31 Billion JPY | -70.015% |
| Takara Bio Inc. | 123.2 Billion JPY | 95.427% |
| ReproCELL Incorporated | 9.05 Billion JPY | 37.762% |
| PhoenixBio Co., Ltd. | 2.71 Billion JPY | -107.495% |
| StemCell Institute Inc. | 6.54 Billion JPY | 13.891% |
| Japan Tissue Engineering Co., Ltd. | 6.98 Billion JPY | 19.383% |
| CellSeed Inc. | 2.46 Billion JPY | -128.495% |